Alliancebernstein L.P. Haemonetics Corp Transaction History

Alliancebernstein L.P.

$261 Billion
Q1 2025

A detailed history of Alliancebernstein L.P. transactions in Haemonetics Corp stock. As of the latest transaction made, Alliancebernstein L.P. holds 98,999 shares of HAE stock, worth $7.09 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

98,999

Previous 99,781 0.78%

Holding current value

$7.09 Million

Previous $7.79 Million 19.24%

% of portfolio

0.0%

Previous 0.0%

31 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 15, 2025	SELL	$59.34 - $80.05 $46,403 - $62,599	-782 Reduced 0.78%	98,999 $6.29 Million
Q4 2024 Feb 12, 2025	SELL	$71.16 - $93.38 $609,414 - $799,706	-8,564 Reduced 7.9%	99,781 $7.79 Million
Q3 2024 Nov 14, 2024	SELL	$72.45 - $91.58 $101,140 - $127,845	-1,396 Reduced 1.27%	108,345 $8.71 Million
Q2 2024 Aug 14, 2024	BUY	$81.24 - $97.37 $7,392 - $8,860	91 Added 0.08%	109,741 $9.08 Million
Q1 2024 May 14, 2024	SELL	$71.24 - $85.35 $91,258 - $109,333	-1,281 Reduced 1.15%	109,650 $9.36 Million
Q4 2023 Feb 14, 2024	SELL	$80.59 - $92.61 $126,606 - $145,490	-1,571 Reduced 1.4%	110,931 $9.49 Million
Q3 2023 Nov 14, 2023	SELL	$82.56 - $93.49 $1.23 Million - $1.39 Million	-14,883 Reduced 11.68%	112,502 $10.1 Million
Q2 2023 Aug 15, 2023	BUY	$80.84 - $89.45 $890,695 - $985,560	11,018 Added 9.47%	127,385 $10.8 Million
Q1 2023 May 15, 2023	SELL	$72.75 - $90.6 $95,448 - $118,867	-1,312 Reduced 1.11%	116,367 $9.63 Million
Q4 2022 Feb 14, 2023	SELL	$73.85 - $86.14 $13,219 - $15,419	-179 Reduced 0.15%	117,679 $9.26 Million
Q3 2022 Nov 15, 2022	SELL	$63.3 - $78.66 $38,549 - $47,903	-609 Reduced 0.51%	117,858 $8.73 Million
Q2 2022 Aug 15, 2022	BUY	$49.27 - $66.08 $35,425 - $47,511	719 Added 0.61%	118,467 $7.72 Million
Q1 2022 May 13, 2022	SELL	$43.77 - $63.22 $9,892 - $14,287	-226 Reduced 0.19%	117,748 $7.44 Million
Q4 2021 Feb 14, 2022	SELL	$49.55 - $74.59 $2,527 - $3,804	-51 Reduced 0.04%	117,974 $6.26 Million
Q3 2021 Nov 10, 2021	SELL	$57.6 - $70.59 $132,019 - $161,792	-2,292 Reduced 1.9%	118,025 $8.33 Million
Q2 2021 Jul 30, 2021	BUY	$51.81 - $118.56 $1.78 Million - $4.08 Million	34,371 Added 39.99%	120,317 $8.02 Million
Q1 2021 May 06, 2021	BUY	$111.01 - $139.48 $103,794 - $130,413	935 Added 1.1%	85,946 $9.54 Million
Q4 2020 Feb 08, 2021	SELL	$88.75 - $119.95 $123,273 - $166,610	-1,389 Reduced 1.61%	85,011 $10.1 Million
Q3 2020 Nov 12, 2020	SELL	$75.65 - $93.58 $935,790 - $1.16 Million	-12,370 Reduced 12.52%	86,400 $7.54 Million
Q2 2020 Aug 13, 2020	SELL	$84.96 - $118.91 $7.33 Million - $10.3 Million	-86,250 Reduced 46.62%	98,770 $8.85 Million
Q1 2020 May 14, 2020	BUY	$74.34 - $121.82 $2.38 Million - $3.89 Million	31,970 Added 20.89%	185,020 $18.4 Million
Q4 2019 Feb 18, 2020	SELL	$114.37 - $129.46 $1.87 Million - $2.12 Million	-16,360 Reduced 9.66%	153,050 $17.6 Million
Q3 2019 Nov 14, 2019	SELL	$117.16 - $138.52 $829,492 - $980,721	-7,080 Reduced 4.01%	169,410 $21.4 Million
Q2 2019 Aug 14, 2019	SELL	$81.74 - $120.34 $24,522 - $36,102	-300 Reduced 0.17%	176,490 $21.2 Million
Q1 2019 May 14, 2019	SELL	$83.25 - $102.12 $394,605 - $484,048	-4,740 Reduced 2.61%	176,790 $15.5 Million
Q4 2018 Feb 13, 2019	BUY	$90.66 - $116.63 $5.25 Million - $6.75 Million	57,910 Added 46.85%	181,530 $18.2 Million
Q3 2018 Nov 08, 2018	SELL	$89.96 - $114.58 $410,217 - $522,484	-4,560 Reduced 3.56%	123,620 $14.2 Million
Q2 2018 Aug 13, 2018	BUY	$71.53 - $95.75 $601,567 - $805,257	8,410 Added 7.02%	128,180 $11.5 Million
Q1 2018 May 14, 2018	BUY	$60.72 - $74.41 $2.38 Million - $2.91 Million	39,164 Added 48.59%	119,770 $8.76 Million
Q4 2017 Feb 13, 2018	BUY	$44.96 - $58.99 $9,711 - $12,741	216 Added 0.27%	80,606 $4.68 Million
Q3 2017 Nov 13, 2017	BUY	$40.38 - $44.87 $3.25 Million - $3.61 Million	80,390	80,390 $3.61 Million

Others Institutions Holding HAE

# of Institutions

351

Shares Held

53.3M

Call Options Held

417K

Put Options Held

314K

View Full List

About HAEMONETICS CORP

Ticker HAE
Exchange NYSE
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 51,316,500
Market Cap $3.68B
Description
Haemonetics Corporation, a healthcare company, provides medical products and solutions. It operates through three segments: Plasma, Blood Center, and Hospital. The company offers automated plasma collection devices, related disposables, and software, including NexSys PCS and PCS2 plasmapheresis equipment and related disposables and intravenous s...

More about HAE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Alliancebernstein L.P., based on Form 13F filings with the SEC.

News

Stay updated on Alliancebernstein L.P. with notifications on news.

Account

Alliancebernstein L.P. Haemonetics Corp Transaction History